Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jan Drappatz. (2022) How useful is chemotherapy for atypical and anaplastic meningiomas?. Expert Opinion on Pharmacotherapy 23:14, pages 1559-1561.
Read now
Read now
Articles from other publishers (17)
Ruoran Wang, Jing Zhang, Min He & Jianguo Xu. (2023) Nomogram for predicting cardiovascular disease mortality in patients with meningioma: a competing risk analysis. Neurosurgical Review 47:1.
Crossref
Crossref
Katherine Belanger, Timothy H. Ung, Denise Damek, Kevin O. Lillehei & D. Ryan Ormond. (2022) Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. BMC Cancer 22:1.
Crossref
Crossref
Jenny Pettersson-Segerlind, Alexander Fletcher-Sandersjöö, Ann-Christin von Vogelsang, Oscar Persson, Lars Kihlström Burenstam Linder, Petter Förander, Tiit Mathiesen, Erik Edström & Adrian Elmi-Terander. (2022) Long-Term Follow-Up, Treatment Strategies, Functional Outcome, and Health-Related Quality of Life after Surgery for WHO Grade 2 and 3 Intracranial Meningiomas. Cancers 14:20, pages 5038.
Crossref
Crossref
Thomas Graillon, Emeline Tabouret & Olivier Chinot. (2021) Chemotherapy and targeted therapies for meningiomas: what is the evidence?. Current Opinion in Neurology 34:6, pages 857-867.
Crossref
Crossref
Christine Marosi. (2021) Will mastering ferroptosis allow treating refractory meningiomas?. Neuro-Oncology 23:12, pages 1989-1990.
Crossref
Crossref
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Daniele Angelini, Stefania Bartolini, Raffaele Lodi & Alba Ariela Brandes. (2021) Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets. Diagnostics 11:10, pages 1852.
Crossref
Crossref
Scott Raskin & Miriam Bornhorst. (2021) Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders. Otolaryngologic Clinics of North America 54:4, pages 789-801.
Crossref
Crossref
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi & Alba A Brandes. (2021) Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncology 10:2.
Crossref
Crossref
Kunal S. Patel, Sameer Kejriwal, Michel M. Sun, Samasuk Thammachantha, Courtney Duong, Ann Chan, Nina Cherian, Prasanth Romiyo, Lynn K. Gordon, William Yong, Madhuri Wadehra & Isaac Yang. (2020) Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Journal of Neuro-Oncology 147:1, pages 15-24.
Crossref
Crossref
Andrés F. Cardona, Alejandro Ruiz-Patiño, Zyanya Lucia Zatarain-Barrón, Fernando Hakim, Enrique Jiménez, Juan Armando Mejía, Juan Fernando Ramón, Nicolás Useche, Sonia Bermúdez, Diego Pineda, Hernando Cifuentes, Leonardo Rojas, Luisa Ricaurte, Luis Eduardo Pino, Carmen Balaña & Oscar Arrieta. (2019) Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib. PLOS ONE 14:6, pages e0217340.
Crossref
Crossref
Constantin A Dasanu, Yazeed Samara, Ion Codreanu, Farhad M Limonadi, Omid Hamid & Juliana Alvarez-Argote. (2018) Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?. Journal of Oncology Pharmacy Practice 25:3, pages 638-647.
Crossref
Crossref
Moncef Berhouma, Timothee Jacquesson, Emmanuel Jouanneau & François Cotton. (2017) Pathogenesis of peri-tumoral edema in intracranial meningiomas. Neurosurgical Review 42:1, pages 59-71.
Crossref
Crossref
Robin A Buerki, Craig M Horbinski, Timothy Kruser, Peleg M Horowitz, Charles David James & Rimas V Lukas. (2018) An overview of meningiomas. Future Oncology 14:21, pages 2161-2177.
Crossref
Crossref
Richard G. Everson, Yuuri Hashimoto, Jacob L. Freeman, Tiffany R. Hodges, Jason Huse, Shouhao Zhou, Joanne Xiu, David Spetzler, Nader Sanai, Lyndon Kim, Santosh Kesari, Andrew Brenner, Franco De Monte, Amy Heimberger & Shaan M. Raza. (2018) Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design. Journal of Neuro-Oncology 139:2, pages 469-478.
Crossref
Crossref
Hiroyuki Takeda, Masashi Okada, Kenta Kuramoto, Shuhei Suzuki, Hirotsugu Sakaki, Tomomi Sanomachi, Shizuka Seino, Takashi Yoshioka, Hirofumi Hirano, Kazunori Arita & Chifumi Kitanaka. (2017)
Antitumor activity of gemcitabine against high-grade meningioma
in vitro
and
in vivo
. Oncotarget 8:53, pages 90996-91008.
Crossref
Crossref
Thomas Graillon, David Romano, Céline Defilles, Christophe Lisbonis, Alexandru Saveanu, Dominique Figarella-Branger, Pierre-Hugues Roche, Stéphane Fuentes, Olivier Chinot, Henry Dufour & Anne Barlier. (2017)
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma
in vitro
. Oncotarget 8:33, pages 55361-55373.
Crossref
Crossref
William L. Read & Felicia Williams. (2017) Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin. Case Reports in Oncology 10:2, pages 656-659.
Crossref
Crossref